Shining Forward
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Shining Forward
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Accelerating Market Entry, Creating a Product with Value, Attracting Investment
Eliomedica, a medical device innovation firm, bridges the gaps between regulatory, business, and development strategies to ensure seamless commercialization. With expertise spanning IVDs, sterilization systems, RPM devices, SaMD, and more, our integrated approach empowers startups to:
• Create Products with Value
• Accelerate Market Entry
• Attract Investment
We are technology enabled, leveraging Nyquist AI global intelligence platform with clinical, regulatory and medical device data.
We combine engineering, regulatory, and commercialization expertise to transform innovative medical technologies into market-ready products. By leveraging first-principle thinking and systems engineering principles, we address challenges for novel, medium- to high-risk devices from concept to launch — and beyond.
We are committed to delivering agile solutions, strategic insights, and lasting partnerships. Based in Toronto, we work with clients across North America. Contact us to bring your innovation to market.
- Early stage to VC-backed startups
- Spin-offs from large organizations
- Physician entrepreneurs
- MedTech investment firms
- Hospital innovation hubs
Founder & Managing Partner
Market Entry Strategy
Highlights:
Ecosystem Partner, EEE Corp Group
Business Dev, StarFish Medical
Systems Eng, Synaptive Medical
Partner
Sales & Go-to-Market Strategy
Highlights:
Business Dev & Investor, MediPines
Business Dev & investor, Pramptex
Sr Consultant
Regulatory Strategy
Highlights:
Founder, MedEdge Regulatory
Director at Arterys, RA at Stryker
Consultant
Design & Communications Strategy
Highlights:
Human Factors Eng, StarFish Medical
Design Researcher, SleepLabs
Sr Consultant
Product Development Strategy
Highlights:
Program Mgr, StarFish Medical
Director, Major manufacturing
Advisor
Health Data & AI Strategy
Highlights:
Head, Ontario Brain Institute
Director, UHN
Advisor
Regulatory & Business Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
ElioMedica has been an invaluable partner for NovaTechs, offering exceptional regulatory consulting with a unique blend of expertise, deep knowledge, and an innovative approach. Their method not only supports startups like ours in navigating complex regulatory landscapes but also empowers us to learn and implement regulatory practices effectively. I genuinely look forward to our meetings with ElioMedica - a rare sentiment for regulatory discussions - because of the passion and insight they bring to the table. Each interaction is an opportunity to grow, and their dedication to fostering understanding makes the process both engaging and educational. I wholeheartedly recommend ElioMedica to anyone seeking a partner who combines technical excellence with a collaborative and inspiring approach.
Mohammad Nasiri, PhD
Founder & CEO, NovaTechs
---
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
Dr. Anya McLaren-Barnett, MD
Founder, The Sleep Health Organization
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
Founder & CEO, Deep Breathe AI